ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625731 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625731; 2) Community: the network communities that were significantly associated with the response to NSC 625731; 3) Molecule: the relationships between components within communities and NSC 625731; 4) MDR: the compounds that were significantly associated with the NSC 625731.

NSC Compound Enrichment Correlation
NSC 694234 Null 0.0114553853234976 -0.28005473
NSC 695945 Null 0.0114553853234976 0.33985778
NSC 716679 Null 0.0114553853234976 0.3114617
NSC 718530 Null 0.0114553853234976 0.45380956
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0114553853234976 0.51284374
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.0114553853234976 -0.30170157
NSC 106486 Formycin B 0.013789112253851 0.10780191
NSC 248040 Null 0.013789112253851 0.48079164
NSC 335753 HELIANGOLIDE 0.013789112253851 0.50355272
NSC 626880 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-hydroxy- phenyl)methylene]-, hydrochloride 0.013789112253851 0.49733913
Total:89  Current:34    [First] [Prev] [Next] [Last]